טוען...
Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin
The genes encoding the cytochrome P450 2C9 enzyme (CYP2C9) and vitamin K-epoxide reductase complex unit 1 (VKORC1) are major determinants of anticoagulant response to warfarin. Together with patient demographics and clinical information, they account for approximately one-half of the warfarin dose v...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4134937/ https://ncbi.nlm.nih.gov/pubmed/23041981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0032-1328891 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|